US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPS Medical Breakthroughs ETF

67.52

+0.21280.32%

Volume:23.61K

Turnover:1.59M

Market Cap:243.08M

PE:- -

High:67.56

Open:67.09

Low:66.97

Close:67.31

52wk High:70.85

52wk Low:35.43

Shares:3.60M

Float Shares:3.60M

Volume Ratio:0.83

T/O Rate:0.66%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live

AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics

MT Newswires Live

Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/SBIO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","market":"US","secType":"STK","nameCN":"ALPS Medical Breakthroughs ETF","latestPrice":67.5228,"timestamp":1788548587032,"preClose":67.31,"halted":0,"volume":23607,"delay":0,"changeRate":0.003161491606002101,"floatShares":3600000,"shares":3600000,"eps":0,"marketStatus":"Trading","change":0.2128,"latestTime":"09-04 15:04:29 EDT","open":67.085,"high":67.56,"low":66.965,"amount":1589864.40612,"amplitude":0.00884,"askPrice":67.63,"askSize":200,"bidPrice":67.51,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788552000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":67.31,"sharesOutstanding":2675000,"nav":67.77,"aum":243975496.73,"bidAskSpread":0.002223,"preHourTrading":{"tag":"盘前","latestPrice":67.57,"preClose":67.31,"latestTime":"07:37 EDT","volume":3,"amount":202.70999999999998,"timestamp":1788521835899,"change":0.26,"changeRate":0.003863,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":67.31,"preClose":67.31,"latestTime":"19:30 EDT","volume":13,"amount":874.78,"timestamp":1788478206973,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.831511,"impliedVol":0.2136,"impliedVolPercentile":0.6825},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","floatShares":3600000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.831511,"shares":3600000,"dividePrice":0,"high":67.56,"amplitude":0.00884,"preClose":67.31,"low":66.965,"week52Low":35.43,"pbRate":"--","week52High":70.85,"institutionHeld":0,"latestPrice":67.5228,"committee":-0.333333,"eps":0,"divideRate":0,"volume":23607,"delay":0,"ttmEps":0,"open":67.085,"prevYearClose":51.22,"prevWeekClose":67.09,"prevMonthClose":66.82,"prevQuarterClose":64.65,"fiveDayClose":67.09,"twentyDayClose":67.614,"sixtyDayClose":50.5209},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBIO\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"SBIO","amount":1.17346,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-19","defaultRemindTime":1734618600000,"name":"ALPS Medical Breakthroughs ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-19","currency":"USD","dateTimestamp":1734584400000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"SBIO","amount":0.07106,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"},{"market":"US","date":"2019-12-19","symbol":"SBIO","amount":0.01585,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2019-12-27","payableDate":"2019-12-20","currency":"USD","type":"dividend","dateTimestamp":1576731600000},{"market":"US","date":"2018-12-20","symbol":"SBIO","amount":0.78406,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2018-12-27","payableDate":"2018-12-21","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBIO\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.78406,"currency":"USD"},{"executeDate":"2019-12-19","recordDate":"2019-12-20","paymentDate":"2019-12-27","value":0.01585,"currency":"USD"},{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.07106,"currency":"USD"},{"executeDate":"2024-12-19","recordDate":"2024-12-19","paymentDate":"2024-12-26","value":1.17346,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBIO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBIO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127014248","title":"AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1127014248","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127014248?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:44","pubTimestamp":1788486257,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE: ABBV) announced on Thursday that it has finalized its $10.9 billion acquisition of inflammation drug developer Apogee Therapeutics (NASDAQ: APGE). This transaction marks the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689605.HKD","LU0069063385.USD","IE00BDGV0183.EUR","LU0289739699.SGD","LU2112291526.USD","LU1496350171.SGD","FTXH","LU0823416689.USD","LU0868494617.USD","IE00BN8TJ469.HKD","IE00BGHQF631.EUR","LU0211328371.USD","LU2089283258.USD","LU2125909247.SGD","SG9999015986.USD","LU1670627923.USD","LU0985320562.USD","ABBV","LU2347655156.SGD","IE00BBT3K403.USD","LU2129689431.USD","LU0882574055.USD","IE00B19Z3B42.SGD","MEDX","IE000F7OJYX1.SGD","LU1061106388.HKD","LU1244550577.SGD","PPH","TRUH","LU1244550221.USD","LU2347655073.USD","IYH","LU0689626769.HKD","LU1551013425.SGD","LU0661504455.SGD","LU0198837287.USD","LU1267930573.SGD","LU0124676726.USD","LU0949170772.SGD","LU1093756325.SGD","LU0203347892.USD","BK4585","SBIO","LU2237443549.SGD","SG9999001440.SGD","LU1496350502.SGD","LU1923622614.USD","LU0256863811.USD","LU0128525929.USD","XMMO","BK4534","LU2433249047.HKD","LU0234572021.USD","LU1162221912.USD","LU0795875169.SGD","MYLD","GLAM","LU1670628061.USD","SG9999003800.SGD","LU0203345920.USD","LU2129689514.USD","BK4139","SG9999011175.SGD","LU0868494708.USD","IE000MB6IJN5.SGD","LU0511384066.AUD","LU1929549753.HKD","LU0689472784.USD","LU1430594728.SGD","LU1983299246.USD","IE00B42XCP33.USD","LU0395794307.EUR","IE000BZT7R73.USD","LU0965509101.SGD","LU1267930490.SGD","LU0553294199.USD","LU1989772923.USD","LU2089984988.USD","IE000SO60NU8.SGD","LU1037948897.HKD","LU0456855351.SGD","IE00BLSP4239.USD","LU0943347566.SGD","IE0004445239.USD","IE00B3PB1722.GBP","LU0545039389.USD","IE0002270589.USD","LU2087621335.USD","XLV","LU0310800379.SGD","LU0965509010.AUD","VHT","LU0289739343.SGD","FHLC","IE00BFTCPJ56.SGD","IXJ","LU2357627491.SGD","LU1236620750.USD","IE00B2B36J28.USD","RXL","LU0965508806.USD","LU1236620834.HKD","LU0965509283.SGD","LU1989771016.USD","SG9999015978.USD","LU0795875086.SGD","LU1989772840.SGD","LU1074936037.SGD","LU1244550494.USD","LU0820561818.USD","LU0058720904.USD","LU0289961442.SGD","IE0000B7K699.USD","LU2237443622.USD","IE00BVYPNV92.GBP","IE00BSNM7G36.USD","LU1732800096.USD","CALF","LU0114720955.EUR","IE00BLSP4452.SGD","SG9999015945.SGD","LU0320765646.SGD","LU0234570918.USD","IE00BVYPNW00.USD","LU2237443895.HKD","IE0002141913.USD","LU0029864427.USD","PJP","LU0158827948.USD","LU1585245621.USD","AGNG","BK4550","KCE","LU2089284900.SGD","LU0942090050.USD","LU2237443465.HKD","LU0256863902.USD","LU1934455194.USD","LU1718418525.SGD","SG9999015952.SGD","LU0211327993.USD","LU1291159041.SGD","BK4581","LU1551013342.USD","LU0170899867.USD","LU0053671581.USD","LU2023251221.USD","LU2237443978.SGD","BK4533","LU2237443382.USD","LU0859254822.USD","LU1057294990.SGD","LU0057025933.USD","BK4588","LU1023059063.AUD","LU0098860793.USD","LU1093756168.USD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","BK4566","LU0912757837.SGD","LU0432979614.USD","LU0820561909.HKD","LU1934455863.HKD","LU0417517546.SGD","LU1934455277.USD","LU2133065610.SGD","IE0009355771.USD","LU1839511570.USD","IE000WAW04H5.SGD","LU0122379950.USD","LU0310799852.SGD","APGE","LU0861579265.USD","LU1003077747.HKD","LU0708994859.HKD","LU0472753341.HKD","LU1037948541.HKD","IE00B4R5TH58.HKD","LU2125909593.SGD","LU0726765562.USD","BK4559","IE00BJT1NW94.SGD","LU0738911758.USD","JDOC","LU1732799900.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080500","title":"Sector Update: Healthcare Stocks Higher Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080500?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:49","pubTimestamp":1788457760,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Hutchmed  shares jumped 17% after the company said its unit licensed rights to GSK  to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.3%.Ultragenyx Pharmaceutical  shares fell 45% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0004445239.USD","FHLC","JDOC","LU0708994859.HKD","LU2125909593.SGD","LU2237443382.USD","LU0029864427.USD","LABU","LU0256863811.USD","LU0128525929.USD","LU0432979614.USD","PJP","XLV","MEDX","BK4534","LU1718418525.SGD","APGE","IXJ","RARE","GLAM","IE00BGHQF631.EUR","LU1236620750.USD","IBB","RXL","SBIO","TRUH","XBI","HCSG","IE00B4R5TH58.HKD","LU0124676726.USD","ABBV","LU0114720955.EUR","HCM","LU0820561909.HKD","IYH","VHT","GSK.UK","BK4137","PPH","IE00BJJMRZ35.SGD","AGNG","LU0553294199.USD","LU0203345920.USD","LU1989772923.USD","FTXH","LU1244550577.SGD","LU1496350171.SGD","GSK","GSKH","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664720938","title":"AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664720938","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664720938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:13","pubTimestamp":1788441193,"startTime":"0","endTime":"0","summary":"AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share.The acquisition is expected to negatively impact adjusted diluted earnings per share by $0.14 in 2026 and by approximately $0.46 in 2027, with accretion beginning in 2032, AbbVie said.Apogee Therapeutics' stock ceased trading on the Nasdaq stock exchange prior to the market open on Sept. 3, according to a statement.AbbVie said it continues to expect Q3 adjusted diluted EPS in the range of $3.84 to $3.88, and full-year adjusted diluted EPS between $13.87 to $14.07.Analysts polled by FactSet expect $3.86 and $14.03, respectively.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0310799852.SGD","LU0965509101.SGD","PPH","APGE","RXL","LU1244550494.USD","FHLC","TRUH","LU1923622614.USD","LU0738911758.USD","LU0320765646.SGD","FTXH","LU0949170772.SGD","GLAM","LU1037948897.HKD","PJP","MEDX","LU2125909247.SGD","LU0417517546.SGD","VHT","LU0795875086.SGD","LU0057025933.USD","LU0432979614.USD","LU0965509010.AUD","AGNG","IYH","LU0456855351.SGD","LU0985320562.USD","IE00BJJMRZ35.SGD","LU2237443622.USD","SG9999011175.SGD","IXJ","IE00BVYPNV92.GBP","LU0289739343.SGD","ABBV","LU1023059063.AUD","LU1093756325.SGD","IE00B19Z3B42.SGD","LU1061106388.HKD","SBIO","LU1267930573.SGD","LU0069063385.USD","IE00BBT3K403.USD","JDOC","XLV","LU2089283258.USD","LU2129689514.USD","LU2237443382.USD","LU0795875169.SGD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872503","title":"Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872503","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872503?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:54","pubTimestamp":1788440071,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics shares face Nasdaq suspension as company moves to delist after AbbVie mergerApogee notified Nasdaq of its merger close, requesting delisting and continued trading halt; shares suspended from trading Sept. 4, 2026.Nasdaq to file SEC Form 25 to delist and deregister the stock under Exchange Act Section 12.Company plans to file SEC Form 15 to terminate registration under Section 12, suspending reporting obligations under Sections 13 and 15.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 03, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3D254h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","LU2133065610.SGD","LU0943347566.SGD","FTXH","LU0965508806.USD","IE00BN8TJ469.HKD","LU2237443549.SGD","AGNG","LU0128525929.USD","MEDX","XLV","LU0320765646.SGD","LU2468319806.SGD","IE00B19Z3581.USD","PPH","PJP","LU1989771016.USD","LU2237443382.USD","APGE","LU2129689514.USD","LU0882574055.USD","SBIO","IE000MB6IJN5.SGD","LU2089284900.SGD","LU0868494708.USD","VHT","ABBV","LU0820561909.HKD","LU1670627923.USD","IE000F7OJYX1.SGD","IE00BJJMRZ35.SGD","IYH","JDOC","LU2347655073.USD","LU2237443895.HKD","LU1934455277.USD","GLAM","LU0985320562.USD","BK4534","LU2112291526.USD","LU2347655156.SGD","TRUH","LU1061106388.HKD","IXJ","RXL","IE00B4R5TH58.HKD","FHLC","SG9999003800.SGD","IE00B3PB1722.GBP","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":21,"pageCount":1,"totalSize":83,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SBIO\",params:#limit:6,delay:false,,,undefined,":[]}}